Skip to main content
logo
Eli Lilly and Company (LLY)
NYSE: LLY · Real-Time Price · USD
1,007.17
-8.58 (-0.84%)
May 14, 2026, 10:39 AM EDT - Market open

Eli Lilly Revenue by Segment

Period EndingMar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017Sep 30, 2017Jun 30, 2017Mar 31, 2017Dec 31, 2016
Cardiometabolic
54.77B48.22B42.84B37.06B33.24B29.52B26.16B23.47B
Cardiometabolic Growth
64.80%63.35%63.74%57.90%58.49%50.10%46.17%39.40%
Oncology
9.70B9.38B9.32B9.14B8.89B8.75B8.08B7.60B
Oncology Growth
9.07%7.12%15.29%20.33%24.99%31.45%25.83%27.27%
Immunology
5.36B5.25B5.00B4.82B4.65B4.39B4.21B4.01B
Immunology Growth
15.39%19.44%18.79%20.28%20.59%15.68%15.98%14.30%
Neuroscience
1.50B1.39B1.32B1.36B1.36B1.47B1.44B2.86B
Neuroscience Growth
10.65%-5.60%-8.19%-52.40%-53.34%-48.81%-50.26%89.84%
Other
917.10M943.00M942.20M867.80M873.90M902.90M968.50M981.80M
Other Growth
4.94%4.44%-2.72%-11.61%-19.74%-19.54%-20.74%-41.97%

Revenue by Geography

Period EndingMar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017Sep 30, 2017Jun 30, 2017Mar 31, 2017Dec 31, 2016
United States
47.11B43.48B39.64B36.15B33.17B30.38B27.80B25.35B
United States Growth
42.03%43.15%42.58%42.58%43.91%39.39%39.03%33.10%
Europe
12.82B11.56B10.91B9.04B7.87B6.92B5.81B6.75B
Europe Growth
62.85%67.01%87.76%33.91%20.61%12.08%-1.71%53.44%
Rest of World
7.83B6.06B4.93B4.35B4.38B4.27B3.95B3.62B
Rest of World Growth
78.98%41.81%24.78%20.08%38.20%44.97%30.64%25.97%
Japan
2.30B2.13B2.04B1.91B1.85B1.81B1.69B1.66B
Japan Growth
24.19%17.48%20.18%15.38%12.34%8.50%4.06%-4.00%
China
2.19B1.95B1.91B1.81B1.74B1.66B1.61B1.54B
China Growth
26.40%17.52%18.52%17.31%12.43%7.83%6.28%5.01%

Operating Expense Breakdown

Period EndingMar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017Sep 30, 2017Jun 30, 2017Mar 31, 2017Dec 31, 2016
Research and Development
14.11B13.34B12.56B11.83B11.20B10.99B10.53B10.21B
Research and Development Growth
25.99%21.35%19.25%15.88%13.71%18.01%20.40%25.37%
Marketing, Selling, and Administrative
11.56B11.09B10.39B9.75B9.11B8.59B8.09B7.80B
Marketing, Selling, and Administrative Growth
26.88%29.09%28.33%24.98%19.78%16.08%13.65%12.49%
Acquired In-Process Research and Development
1.92B2.91B2.57B4.74B4.74B3.28B3.71B3.86B
Acquired In-Process Research and Development Growth
-59.46%-11.29%-30.79%22.75%24.61%-13.67%8.68%665.46%
Impairment, Restructuring, and Other
728.00M484.00M743.90M460.60M895.60M860.60M523.37M441.77M
Impairment, Restructuring, and Other Growth
-18.71%-43.76%42.14%4.26%13,128.95%12,611.96%1,273.67%80.61%
Source: Business metrics provided by TipRanks and sourced from official company press releases and documents.